Complicated Enterobacter peritonitis

Complicated *Enterobacter* peritonitis is a severe, deep-seated intra-abdominal infection characterized by inflammation of the peritoneum caused by the Gram-negative bacterial genus *Enterobacter*

Complicated *Enterobacter* peritonitis is a severe, deep-seated intra-abdominal infection characterized by inflammation of the peritoneum caused by the Gram-negative bacterial genus *Enterobacter* This clinical state typically arises in hospitalized patients, individuals undergoing peritoneal dialysis, or patients experiencing gastrointestinal tract perforation, anastomotic leak, or postsurgical abdominal complications

This clinical state typically arises in hospitalized patients, individuals undergoing peritoneal dialysis, or patients experiencing gastrointestinal tract perforation, anastomotic leak, or postsurgical abdominal complications

This clinical state typically arises in hospitalized patients, individuals undergoing peritoneal dialysis, or patients experiencing gastrointestinal tract perforation, anastomotic leak, or postsurgical abdominal complications

Pathophysiologically, the infection extends beyond a single hollow organ into the normally sterile peritoneal cavity, precipitating localized or diffuse peritonitis and often resulting in intra-abdominal abscess formation or systemic sepsis

Pathophysiologically, the infection extends beyond a single hollow organ into the normally sterile peritoneal cavity, precipitating localized or diffuse peritonitis and often resulting in intra-abdominal abscess formation or systemic sepsis

Clinically, it manifests with acute abdominal pain, tenderness, fever, and leukocytosis, frequently complicated by the intrinsic ability of *Enterobacter* species to express inducible AmpC beta-lactamases or other multi-drug resistance mechanisms that increase the risk of treatment failure

Clinically, it manifests with acute abdominal pain, tenderness, fever, and leukocytosis, frequently complicated by the intrinsic ability of *Enterobacter* species to express inducible AmpC beta-lactamases or other multi-drug resistance mechanisms that increase the risk of treatment failure

Clinically, it manifests with acute abdominal pain, tenderness, fever, and leukocytosis, frequently complicated by the intrinsic ability of *Enterobacter* species to express inducible AmpC beta-lactamases or other multi-drug resistance mechanisms that increase the risk of treatment failure